BamSEC and AlphaSense Join Forces
Learn More

Cocrystal Pharma Inc.

NASDAQ: COCP    
Share price (1/6/25): $2.40    
Market cap (1/6/25): $24.4 million
Search in Documents
Key Exhibits
External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

EX-2.4
from 8-K 1 page Articles of Merger
12/34/56
EX-2.3
from 8-K 1 page State of Delaware Certificate of Merger of a Domestic Limited Liability Company Into a Foreign Limited Liability Company
12/34/56
EX-2.2
from 8-K 2 pages Certificate of Merger of Cocrystal Merger Sub, Inc. (A Delaware Corporation) With and Into Cocrystal Pharma, Inc. (A Delaware Corporation) Pursuant to Section 251 of the General Corporation Law of the State of Delaware
12/34/56
EX-2.1
from 8-K 50 pages Agreement and Plan of Merger by and Among Cocrystal Pharma, Inc., Cocrystal Holdings, Inc., Cocrystal Merger Sub, Inc., Rfs Merger Sub, LLC. and Rfs Pharma, LLC. Dated as of November 25, 2014 -1
12/34/56
EX-2.5
from 10-K/A 7 pages Certificate of Merger - Nevada
12/34/56
EX-2.4
from 10-K/A 2 pages Certificate of Merger of Biozone Pharmaceuticals, Inc. (A Nevada Corporation) With and Into Cocrystal Pharma, Inc. (A Delaware Corporation) Pursuant to Section 252 of the General Corporation Law of the State of Delaware
12/34/56
EX-2.5
from 10-K 7 pages Certificate of Merger - Nevada
12/34/56
EX-2.4
from 10-K 2 pages Certificate of Merger of Biozone Pharmaceuticals, Inc. (A Nevada Corporation) With and Into Cocrystal Pharma, Inc. (A Delaware Corporation) Pursuant to Section 252 of the General Corporation Law of the State of Delaware
12/34/56
EX-2.2
from 8-K 2 pages Certificate of Merger of Biozone Acquisitions Co., Inc. (A Delaware Corporation) With and Into Cocrystal Discovery, Inc. (A Delaware Corporation) Pursuant to Section 251 of the General Corporation Law of the State of Delaware
12/34/56
EX-2.1
from 8-K 60 pages Agreement and Plan of Merger by and Among Biozone Pharmaceuticals, Inc., Biozone Acquisitions Co., Inc. and Cocrystal Discovery, Inc. Dated as of January 2, 2014
12/34/56
EX-2.1
from 8-K 54 pages Asset Purchase Agreement by and Among Musclepharm Corporation, Biozone Laboratories Inc., and Biozone Pharmaceuticals, Inc., Biozone Laboratories, Inc., Baker Cummins Corp. and Brian Keller Dated November 12, 2013 Asset Purchase Agreement
12/34/56